Vaccine impact on antimicrobial resistance to inform Gavi, the Vaccine Alliance’s 2018 Vaccine Investment Strategy: report from an expert survey

Background: While the rise of antimicrobial resistance (AMR) has been recognised as a major public health problem, the value of vaccines to control AMR is poorly defined. This expert survey was launched with the aim of informing the 2018 Vaccine Investment Strategy through which Gavi, the Vaccine Al...

Descripción completa

Detalles Bibliográficos
Autores principales: Malarski, Maya, Hasso-Agopsowicz, Mateusz, Soble, Adam, Mok, Wilson, Mathewson, Sophie, Vekemans, Johan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6807152/
https://www.ncbi.nlm.nih.gov/pubmed/31737260
http://dx.doi.org/10.12688/f1000research.20100.1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6807152/
https://www.ncbi.nlm.nih.gov/pubmed/31737260
http://dx.doi.org/10.12688/f1000research.20100.1

Ejemplares similares